|
1
|
Inoue JI, Ishida T, Tsukamoto N, Kobayashi
N, Natio A, Azuma S and Yamamoto T: Tumor necrosis factor
receptor-associated factor (TRAF) family: Adapter proteins that
mediate cytokine signaling. Exp Cell Res. 254:14–24.
2000.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Han F, Zhang L, Qiu W and Yi X: TRAF6
promotes the invasion and metastasis and predicts a poor prognosis
in gastric cancer. Pathol Res Pract. 212:31–37. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tian X, Zhao H, Zhang Z, Guo Z and Li W:
Intestinal mucosal injury induced by obstructive jaundice is
associated with activation of TLR4/TRAF6/NF-κB pathways. PLoS One.
14(e0223651)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Qi Y, Zhao X, Chen J, Pradipta AR, Wei J,
Ruan H, Zhou L, Hsung RP and Tanaka K: In vitro and in vivo cancer
cell apoptosis triggered by competitive binding of Cinchona
alkaloids to the RING domain of TRAF6. Biosci Biotechnol Biochem.
83:1011–1026. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Frede S, Berchner-Pfannschmidt U and
Fandrey J: Regulation of hypoxia-inducible factors during
inflammation. Methods Enzymol. 435:405–419. 2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899.
2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zucchelli S, Codrich M, Marcuzzi F, Pinto
M, Vilotti S, Biagioli M, Ferrer I and Gustincich S: TRAF6 promotes
atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is
localized to Lewy bodies in sporadic Parkinson's disease brains.
Hum Mol Genet. 19:3759–3770. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lamothe B, Besse A, Campos AD, Webster WK,
Wu H and Darnay BG: Site-specific Lys-63-linked tumor necrosis
factor receptor-associated factor 6 auto-ubiquitination is a
critical determinant of I kappa B kinase activation. J Biol Chem.
282:4102–4112. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shi J, Liu Z and Xu Q: Tumor necrosis
factor receptor-associated factor 6 contributes to malignant
behavior of human cancers through promoting AKT ubiquitination and
phosphorylation. Cancer Sci. 110:1909–1920. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhi X, Fang C, Gu Y, Chen H, Chen X, Cui
J, Hu Y, Weng W, Zhou Q, Wang Y, et al: Guaiacol suppresses
osteoclastogenesis by blocking interactions of RANK with TRAF6 and
C-Src and inhibiting NF-κB, MAPK and AKT pathways. J Cell Mol Med.
24:5122–5134. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jang JH, Kim H and Cho JH: Molecular
cloning and functional characterization of TRAF6 and TAK1 in
rainbow trout, Oncorhynchus mykiss. Fish Shellfish Immunol.
84:927–936. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: Rationale and
promise. Cancer Cell. 4:257–262. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Parsons R: Human cancer, PTEN and the PI-3
kinase pathway. Semin Cell Dev Biol. 15:171–176. 2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Scheid MP and Woodgett JR: Unravelling the
activation mechanisms of protein kinase B/Akt. FEBS Lett.
546:108–112. 2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jeong SJ, Pise-Masison CA, Radonovich MF,
Park HU and Brady JN: Activated AKT regulates NF-kappaB activation,
p53 inhibition and cell survival in HTLV-1-transformed cells.
Oncogene. 24:6719–6728. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Landstrom M: The TAK1-TRAF6 signalling
pathway. Int J Biochem Cell Biol. 42:585–589. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Takeuchi O and Akira S: Pattern
recognition receptors and inflammation. Cell. 140:805–820.
2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang C, Deng L, Hong M, Akkaraju GR, Inoue
J and Chen ZJ: TAK1 is a ubiquitin-dependent kinase of MKK and IKK.
Nature. 412:346–351. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Ouyang C, Nie L, Gu M, Wu A, Han X, Wang
X, Shao J and Xia Z: Transforming growth factor (TGF)-β-activated
kinase 1 (TAK1) activation requires phosphorylation of serine 412
by protein kinase A catalytic subunit α (PKACα) and X-linked
protein kinase (PRKX). J Biol Chem. 289:24226–24237.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pugazhenthi S, Nesterova A, Sable C,
Heidenreich KA, Boxer LM, Heasley LE and Reusch JE: Akt/protein
kinase B up-regulates Bcl-2 expression through cAMP-response
element-binding protein. J Biol Chem. 275:10761–10766.
2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wu R, Tang S, Wang M, Xu X, Yao C and Wang
S: MicroRNA-497 induces apoptosis and suppresses proliferation via
the Bcl-2/Bax-caspase9-caspase3 pathway and cyclin D2 protein in
HUVECs. PLoS One. 11(e0167052)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yang WL, Wang J, Chan CH, Lee SW, Campos
AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG and Lin HK: The
E3 ligase TRAF6 regulates Akt ubiquitination and activation.
Science. 325:1134–1138. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Avila M, Martinez-Juarez A, Ibarra-Sanchez
A and Gonzalez-Espinosa C: Lyn kinase controls TLR4-dependent IKK
and MAPK activation modulating the activity of TRAF-6/TAK-1 protein
complex in mast cells. Innate Immun. 18:648–660. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kim SY, Bae S, Choi KH and An S: Hydrogen
peroxide controls Akt activity via ubiquitination/degradation
pathways. Oncol Rep. 26:1561–1566. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Berman HM, Westbrook J, Feng Z, Gilliland
G, Bhat TN, Weissig H, Shindyalov NI and Bourne PE: The protein
data bank. Nucleic Acids Res. 28:235–242. 2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schnetzke U, Fischer M, Kuhn AK,
Spies-Weisshart B, Zirm E, Hochhaus A, Muller JP and Scholl S: The
E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in
FLT3-ITD-positive MV4-11 AML cells. J Cancer Res Clin Oncol.
139:605–615. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yoon K, Jung EJ, Lee SR, Kim J, Choi Y and
Lee SY: TRAF6 deficiency promotes TNF-induced cell death through
inactivation of GSK3beta. Cell Death Differ. 15:730–738.
2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ling MT, Wang XH, Ouyang XS, Xu K, Tsao SW
and Wong YC: Id-1 expression promotes cell survival through
activation of NF-kappaB signaling pathway in prostate cancer cells.
Oncogene. 22:4498–4508. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wen J, Liu X, Qi Y, Niu F, Niu Z, Geng W,
Zou Z, Huang R, Wang J and Zou H: BMP3 suppresses colon
tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling
pathways. J Exp Clin Cancer Res. 38(428)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Starczynowski DT, Lockwood WW, Delehouzee
S, Chari R, Wegrzyn J, Fuller M, Tsao MS, Lam S, Gazdar AF, Lam WL
and Karsan A: TRAF6 is an amplified oncogene bridging the RAS and
NF-κB pathways in human lung cancer. J Clin Invest. 121:4095–4105.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Zhang J, Lei Z, Huang Z, Zhang X, Zhou Y,
Luo Z, Zeng W, Su J, Peng C and Chen X: Epigallocatechin-3-gallate
(EGCG) suppresses melanoma cell growth and metastasis by targeting
TRAF6 activity. Oncotarget. 7:79557–79571. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mercier P, Lewis MJ, Hau DD, Saltibus LF,
Xiao W and Spyracopoulos L: Structure, interactions, and dynamics
of the RING domain from human TRAF6. Protein Sci. 16:602–614.
2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu H, Tamashiro S, Baritaki S, Penichet
M, Yu Y, Chen H, Berenson J and Bonavida B: TRAF6 activation in
multiple myeloma: A potential therapeutic target. Clin Lymphoma
Myeloma Leuk. 12:155–163. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Naito A, Azuma S, Tanaka S, Miyazaki T,
Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T and
Inoue J: Severe osteopetrosis, defective interleukin-1 signalling
and lymph node organogenesis in TRAF6-deficient mice. Genes Cells.
4:353–362. 1999.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yin Q, Lin SC, Lamothe B, Lu M, Lo YC,
Hura G, Zheng L, Rich RL, Campos AD, Myszka DG, et al: E2
interaction and dimerization in the crystal structure of TRAF6. Nat
Struct Mol Biol. 16:658–666. 2009.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chaudhry SI, Hooper S, Nye E, Williamson
P, Harrington K and Sahai E: Autocrine IL-1β-TRAF6 signaling
promotes squamous cell carcinoma invasion through paracrine TNFα
signaling to carcinoma-associated fibroblasts. Oncogene.
32:747–758. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ji YX, Zhang P, Zhang XJ, Zhao YC, Deng
KQ, Jing X, Wang PX, Huang Z and Li H: The ubiquitin E3 ligase
TRAF6 exacerbates pathological cardiac hypertrophy via
TAK1-dependent signaling. Nat Commun. 7(11267)2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li T, Qin JJ, Xia Y, Ji YX, Guo F, Cheng
WL, Wu X, Gong FH, Hong Y, Zhu XY, et al: The ubiquitin E3 ligase
TRAF6 exacerbates ischemic stroke by ubiquitinating and activating
Rac1. J Neurosci. 37:12123–12140. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Paul PK, Bhatnagar S, Mishra V, Srivastava
S, Darnay BG, Choi Y and Kumar A: The E3 ubiquitin ligase TRAF6
intercedes in starvation-induced skeletal muscle atrophy through
multiple mechanisms. Mol Cell Biol. 32:1248–1259. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Dey N, Liu T, Garofalo RP and Casola A:
TAK1 regulates NF-κB and AP-1 activation in airway epithelial cells
following RSV infection. Virology. 418:93–101. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yamashita M, Fatyol K, Jin C, Wang X, Liu
Z and Zhang YE: TRAF6 mediates Smad-independent activation of JNK
and p38 by TGF-beta. Mol Cell. 31:918–924. 2008.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim
Y and Kong G: Id-1 regulates Bcl-2 and Bax expression through p53
and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res
Treat. 112:287–296. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Marsden VS, O'Connor L, O'Reilly LA, Silke
J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ,
et al: Apoptosis initiated by Bcl-2-regulated caspase activation
independently of the cytochrome c/Apaf-1/caspase-9
apoptosome. Nature. 419:634–637. 2002.PubMed/NCBI View Article : Google Scholar
|
|
44
|
McNutt MC, Lagace TA and Horton JD:
Catalytic activity is not required for secreted PCSK9 to reduce low
density lipoprotein receptors in HepG2 cells. J Biol Chem.
282:20799–20803. 2007.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Rahman M, Chan AP, Tang M and Tai IT: A
peptide of SPARC interferes with the interaction between caspase8
and Bcl2 to resensitize chemoresistant tumors and enhance their
regression in vivo. PLoS One. 6(e26390)2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Vegran F, Boidot R, Solary E and
Lizard-Nacol S: A short caspase-3 isoform inhibits
chemotherapy-induced apoptosis by blocking apoptosome assembly.
PLoS One. 6(e29058)2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Cain K, Bratton SB and Cohen GM: The
Apaf-1 apoptosome: A large caspase-activating complex. Biochimie.
84:203–214. 2002.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Qi Y, Pradipta AR, Li M, Zhao X, Lu L, Fu
X, Wei J, Hsung RP, Tanaka K and Zhou L: Cinchonine induces
apoptosis of HeLa and A549 cells through targeting TRAF6. J Exp
Clin Cancer Res. 36(35)2017.PubMed/NCBI View Article : Google Scholar
|
